|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$245,990
|
N/A
|
National Cancer Institute
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-09S3
|
$1,375,035
|
$13,750
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-09
|
$26,766,352
|
$267,664
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
5R01CA098285-08
|
$490,125
|
$490,125
|
ALT, FREDERICK
|
IMMUNE DISEASE INSTITUTE, INC.
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-42S1
|
$125,781
|
$2,516
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-42
|
$2,401,347
|
$48,027
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Children's Oncology Group Statistics and Data Center Grant
|
5U10CA098413-09
|
$5,780,843
|
$57,808
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-32S1
|
$665,444
|
$6,654
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-32
|
$8,893,886
|
$88,939
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs
|
5U10CA037429-27
|
$2,878,195
|
$28,782
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Cancer Center Support Grant
|
3P30CA042014-22S1
|
$75,000
|
$750
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-22
|
$1,409,422
|
$14,094
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Molecule-Guided Investigations into p53 Biology
|
ZIA BC 011261
|
$289,758
|
$43,463
|
Bernal, Federico
|
CCR (NCI)
|
|
Developing Immunoablative Regimens for the Engraftment of Allogeneic HSCT
|
ZIA BC 010698
|
$55,940
|
$8,391
|
Bishop, Michael
|
CCR (NCI)
|
|
Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
|
ZIA BC 011239
|
$55,940
|
$11,188
|
Bishop, Michael
|
CCR (NCI)
|
|
Optimizing the Graft-Versus-Tumor Effect in Allogeneic HSCT
|
ZIA SC 010365
|
$74,587
|
$14,917
|
Bishop, Michael
|
CCR (NCI)
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-02
|
$188,304
|
$1,883
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Cancer Center Support Grant
|
2P30CA016058-35
|
$4,582,303
|
$45,823
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-35S1
|
$5,000
|
$50
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-35S2
|
$49,250
|
$493
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-35S3
|
$140,000
|
$1,400
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
CLL Families-Mayo
|
ZIA CP004410-10312
|
$77,034
|
$3,851
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Novel Approaches to Stem Cell Transplantation
|
5P01CA047741-18
|
$1,781,177
|
$160,306
|
Chao, Nelson
|
DUKE UNIVERSITY
|
|
Biobehavioral Mechanisms Facilitating Recovery From Stem Cell Transplantation
|
1K07CA136966-01A2
|
$148,785
|
$49,099
|
Costanzo, Erin
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Predictors of Optimal Immune Reconstitution in Stem Cell Transplant Patients
|
5R21CA133343-02
|
$156,650
|
$53,261
|
Costanzo, Erin
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Dermatology Consultation Service
|
ZID BC 011317
|
$863,668
|
$259,100
|
Cowen, Edward
|
CCR (NCI)
|
|
SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER
|
5U10CA038926-26
|
$4,603,957
|
$46,040
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer following bone-marrow transplantation
|
ZIA CP010131-04020
|
$135,580
|
$13,557
|
Curtis, Rochelle
|
DCEG (NCI)
|
|
Antibody-based therapeutics and vaccines against AIDS
|
ZIA BC 011155
|
$178,463
|
$89,231
|
Dimitrov, Dimiter
|
CCR (NCI)
|
|
Signal Transduction Pathways in CD30-positive Lymphomas
|
5R01CA142809-02
|
$309,234
|
$154,617
|
DUCKETT, COLIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-24
|
|
$0
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010150-10071
|
$170,909
|
$25,636
|
Engels, Eric
|
DCEG (NCI)
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150-10359
|
$116,720
|
$23,344
|
Engels, Eric
|
DCEG (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150-10362
|
$130,864
|
$13,086
|
Engels, Eric
|
DCEG (NCI)
|
|
Southwest Oncology Group U10 Member Site
|
5U10CA014028-38
|
$349,566
|
$3,496
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,801,787
|
$240,089
|
Fojo, Antonio
|
CCR (NCI)
|
|
City of Hope Lymphoma SPORE
|
2P50CA107399-06A1
|
$2,185,000
|
$1,092,500
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$218,895
|
$21,889
|
Fowler, Daniel
|
CCR (NCI)
|
|
Southwest Oncology Group
|
5U10CA011083-44
|
$355,653
|
$3,557
|
FRIEDBERG, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
Southwest Oncology Group/University of California, Davis
|
5U10CA046441-24
|
$325,239
|
$3,252
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Microbial diversity and human malignancy
|
ZIA CP010214-10419
|
$180,616
|
$36,123
|
Goedert, Jim
|
DCEG (NCI)
|
|
Hodgkin's families
|
ZIA CP004410-08167
|
$76,692
|
$72,857
|
Goldin, Lynn
|
DCEG (NCI)
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803-00355
|
$49,179
|
$9,835
|
Goldin, Lynn
|
DCEG (NCI)
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,833,772
|
$183,377
|
Gress, Ronald
|
CCR (NCI)
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-14
|
$739,271
|
$125,676
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$550,354
|
$110,070
|
Hakim, Frances
|
CCR (NCI)
|
|
Tumor-Infiltrating Donor Derived Lymphocyte Therapy After Allogeneic Transplant
|
ZIC BC 011029
|
$183,451
|
$73,380
|
Hakim, Frances
|
CCR (NCI)
|
|
TAS::75 0849::TAS INCREMENTAL FUNDING
|
N01CO800001-038
|
$221,493,424
|
$6,219
|
HEIMBROOK, DAVID
|
SAIC-FREDERICK, INC.
|
|
SPORE in Lymphoma
|
5P50CA126752-05
|
$2,153,287
|
$602,920
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer following radiotherapy for benign gynecologic disorders
|
ZIA CP010131-04021
|
$19,927
|
$1,195
|
Inskip, Peter
|
DCEG (NCI)
|
Total relevant funding to Hodgkins disease for this search: $13,379,528
|